The purpose of this study is to track the clinical safety and effectiveness of the Pericardium Covered Stent in "real world" use.
This is a multi-center registry of 75 patients treated with the Over and Under/Aneugraft Pericardium Covered Stent (PCS) (IGTI, Israel). The registry will involve the collection of demographic, clinical, and angiographic data on the treated patient population, including in-hospital, 30 day, 6-month, 1 year, 2 years and 3 years clinical follow-up data.
Study Type
OBSERVATIONAL
Enrollment
75
Percutaneous implantation of pericardium covered stent
Sapir Health Center
Cfar Saba, Israel
NOT_YET_RECRUITINGKings College Hospital
London, United Kingdom
RECRUITINGMACE (Major Adverse Clinical Events)
Time frame: 6 months
MACE
MACE is a composite end point of cardiac death, myocardial infarction and target vessel revascularisation (TVR). Each one of the MACE components will be recorded separately
Time frame: 30 days, 1 Year, 2 Years, 3 Years
Hospital readmission due to cardiac reason.
Time frame: 30 days, 6 months. 1 Year, 2 Years, 3 Years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.